-
Are We Measuring What Matters in Postpartum Depression Trials?
Sep 9, 2025, 16:22 PM -
Harmonization of Drug Policy and Regulation Across Europe: A Comparison Between the European Medicines Agency and the European HTA Regulation
Sep 9, 2025, 16:22 PM -
Burden of Disease in Hereditary Transthyretin Amyloidosis With Polyneuropathy in Spain
Sep 9, 2025, 16:22 PM -
Persistence to Basal Insulin and Economic Outcomes Among Patients With Type 2 Diabetes: A Retrospective Analysis Using Electronic Health Records in England
Sep 9, 2025, 16:22 PM -
Complement C5 Inhibitor (Anti-C5) and Neonatal Fc Receptor Antagonist Anti-FcRn in Myasthenia Gravis at University Public Hospitals of Paris, France (AP-HP): What Is the Market Share of These New Treatments?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Secukinumab for Moderate to Severe Hidradenitis Suppurativa in Portugal
Sep 9, 2025, 16:22 PM -
COPD-Asthma Overlap in Brazilian Private Healthcare: Clinical Profiles and Outcomes from a Real-World Analysis
Sep 9, 2025, 16:22 PM -
Optimizing HER2+ Breast Cancer Treatment Pathways in Italian Oncological Centers
Sep 9, 2025, 16:22 PM -
A New Approach for Modeling the Complexity of the Impact of Caring Using the Family and Caregiving Effects
Sep 9, 2025, 16:22 PM -
The Value of Persistence in Neovascular Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018-2022
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Delta Price Cost-Effectiveness Analysis of PCV21 vs. PCV20 Use in Adults Aged ≥18 Years in Austria
Sep 9, 2025, 16:22 PM -
Longitudinal Trends in Biosimilar Uptake in France 2019-2024: Insights by Dispensing Pathway and Prescribing Origin
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Semaglutide 2.4 mg in the Management of People With Obesity and Knee Osteoarthritis in the UK
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Individual Service and Training Interventions for Self-Harm and Suicide Prevention: A Systematic Review
Sep 9, 2025, 16:22 PM -
A Prevalence-Weighted ICER Approach With Scenario Analyses for HTA Without RCT Evidence
Sep 9, 2025, 16:22 PM -
Population Reference Costs for Average Total Annual Care in the UK National Health Service for 11 Common Diseases or Conditions vs. Matched Controls
Sep 9, 2025, 16:22 PM -
Optimizing Healthcare Systems in the MENA Region: Insights From Tailored Reimbursement for Innovative and Generic Essential Remedies (TRIGER) Meetings in Saudi Arabia and Algeria
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Bispecific Antibodies in Europe: A Systematic Review
Sep 9, 2025, 16:22 PM
